ESMO 2018 One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

ESMO 2018: One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

11:46 EDT 20 Oct 2018 | ecancermedicalscience

Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy after one year of treatment, potentially putting themselves at increased risk of recurrence and reduced survival, reported a...

More From BioPortfolio on "ESMO 2018: One in six premenopausal early breast cancer patients do not adhere to hormonal therapy"